TNON
Tenon Medical, Inc.
Price Chart
Latest Quote
$0.20
| Previous Close | $0.20 |
| Open | $0.20 |
| Day High | $0.21 |
| Day Low | $0.20 |
| Volume | 264,381 |
Stock Information
| Shares Outstanding | 17.38M |
| Total Debt | $4.88M |
| Cash Equivalents | $4.61M |
| Revenue | $4.60M |
| Net Income | $-12.42M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $3.50M |
| EPS (TTM) | $-1.00 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $5.67M |
| Sales | $4.60M |
| Income | $-12.42M |
| Book/sh | $-0.10 |
| Cash/sh | $0.27 |
| Employees | 26 |
Financial Ratios
| Quick Ratio | 0.89 |
| Current Ratio | 1.03 |
| Debt/Eq | 257.36 |
Returns & Margins
| ROA | -55.35% |
| ROE | -220.32% |
| Gross Margin | 64.83% |
| Operating Margin | -237.85% |
| Profit Margin | -270.09% |
Ownership
| Insider Ownership | 10.25% |
| Institutional Ownership | 2.11% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -0.33 |
| P/S | 0.76 |
| P/B | -1.94 |
Analyst Data
| Recommendation | none |
| Target Price | $2.62 |
Technical Indicators
| SMA20 | $0.32 |
| SMA50 | $0.54 |
| SMA200 | $0.86 |
| RSI | 1.38 |
| ATR | 0.0420 |
| Shares Float | 10.72M |
| Short Float | 22.70% |
| Short Ratio | 0.14 |
| Volatility | 1.36 |
| Rel Volume | 0.01 |
Performance History
| Week | -10.88% |
| Month | -66.60% |
| Quarter | -75.41% |
| 6 Months | -79.22% |
| YTD | -79.32% |
| Year | -80.25% |
| 3 Years | -99.17% |
| 10 Years | -99.99% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $0.20 | 264,381 |
| 2026-07-16 | $0.20 | 351,300 |
| 2026-07-15 | $0.20 | 651,800 |
| 2026-07-14 | $0.20 | 1,569,000 |
| 2026-07-13 | $0.22 | 929,100 |
| 2026-07-10 | $0.23 | 670,100 |
| 2026-07-09 | $0.23 | 700,700 |
| 2026-07-08 | $0.23 | 1,475,300 |
| 2026-07-07 | $0.25 | 2,516,400 |
| 2026-07-06 | $0.28 | 3,407,400 |
| 2026-07-02 | $0.29 | 71,300,000 |
| 2026-07-01 | $0.33 | 3,568,900 |
| 2026-06-30 | $0.33 | 5,818,400 |
| 2026-06-29 | $0.45 | 1,397,700 |
| 2026-06-26 | $0.51 | 2,600,700 |
| 2026-06-25 | $0.49 | 26,180,200 |
| 2026-06-24 | $0.40 | 3,118,100 |
| 2026-06-23 | $0.46 | 5,936,600 |
| 2026-06-22 | $0.62 | 271,138,200 |
| 2026-06-18 | $0.35 | 33,912,900 |
About Tenon Medical, Inc.
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive inferior-posterior approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
đ° Latest News
Tenon Medical Inc (TNON) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth ...
GuruFocus.com âĸ 2026-05-13T05:01:22ZTenon Medical, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-13T00:20:36ZTenon Medical Inc (TNON) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...
GuruFocus.com âĸ 2026-03-20T03:01:39ZTenon Medical, Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-03-20T00:18:18ZTenon Medical (TNON) Q4 2025 Earnings Transcript
Motley Fool âĸ 2026-03-19T23:38:51ZTenon Medical Inc (TNON) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ...
GuruFocus.com âĸ 2025-11-14T05:04:14ZTenon Medical (TNON) Q3 2025 Earnings Transcript
Motley Fool âĸ 2025-11-13T22:11:40ZTenon Medical Inc (TNON) Q2 2025 Earnings Call Highlights: Strategic Acquisition and Financial ...
GuruFocus.com âĸ 2025-08-14T07:14:49ZBC-Most Active Stocks
Associated Press Finance âĸ 2025-08-01T14:30:19ZIncome Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,586,000 | $1,566,000 | $1,687,000 | $1,332,000 |
| Cost Of Revenue | $1,586,000 | $1,566,000 | $1,687,000 | $1,332,000 |
| Total Revenue | $3,944,000 | $3,277,000 | $2,928,000 | $691,000 |
| Operating Revenue | $3,944,000 | $3,277,000 | $2,928,000 | $691,000 |
| Expenses | ||||
| Interest Expense | $0 | $34,000 | $21,000 | $354,000 |
| Total Expenses | $16,736,000 | $17,043,000 | $18,655,000 | $19,416,000 |
| Other Income Expense | $236,000 | $127,000 | $167,000 | $162,000 |
| Net Non Operating Interest Income Expense | $0 | $-34,000 | $-21,000 | $-354,000 |
| Interest Expense Non Operating | $0 | $34,000 | $21,000 | $354,000 |
| Operating Expense | $15,150,000 | $15,477,000 | $16,968,000 | $18,084,000 |
| Selling And Marketing Expense | $6,026,000 | $5,109,000 | $6,778,000 | $7,833,000 |
| General And Administrative Expense | $6,975,000 | $7,765,000 | $7,027,000 | $7,423,000 |
| Other Non Operating Income Expenses | - | $-56,000 | - | $-18,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-12,556,000 | $-13,673,000 | $-15,581,000 | $-18,917,000 |
| Net Interest Income | $0 | $-34,000 | $-21,000 | $-354,000 |
| Normalized Income | $-12,792,000 | $-13,856,000 | $-15,748,000 | $-19,097,000 |
| Net Income From Continuing And Discontinued Operation | $-12,556,000 | $-13,673,000 | $-15,581,000 | $-18,917,000 |
| Total Operating Income As Reported | $-12,792,000 | $-13,766,000 | $-15,727,000 | $-18,725,000 |
| Net Income Common Stockholders | $-12,556,000 | $-13,673,000 | $-15,581,000 | $-18,917,000 |
| Net Income | $-12,556,000 | $-13,673,000 | $-15,581,000 | $-18,917,000 |
| Net Income Including Noncontrolling Interests | $-12,556,000 | $-13,673,000 | $-15,581,000 | $-18,917,000 |
| Net Income Continuous Operations | $-12,556,000 | $-13,673,000 | $-15,581,000 | $-18,917,000 |
| Pretax Income | $-12,556,000 | $-13,673,000 | $-15,581,000 | $-18,917,000 |
| Operating Income | $-12,792,000 | $-13,766,000 | $-15,727,000 | $-18,725,000 |
| Gross Profit | $2,358,000 | $1,711,000 | $1,241,000 | $-641,000 |
| Per Share | ||||
| Diluted EPS | $-1.70 | $-11.26 | $-68.72 | $-188.96 |
| Basic EPS | $-1.70 | $-11.26 | $-68.72 | $-188.96 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-12,262,000 | $-13,167,000 | $-15,301,000 | $-18,454,000 |
| Total Unusual Items | $236,000 | $183,000 | $167,000 | $180,000 |
| Total Unusual Items Excluding Goodwill | $236,000 | $183,000 | $167,000 | $180,000 |
| Reconciled Depreciation | $530,000 | $655,000 | $426,000 | $289,000 |
| EBITDA (Bullshit earnings) | $-12,026,000 | $-12,984,000 | $-15,134,000 | $-18,274,000 |
| EBIT | $-12,556,000 | $-13,639,000 | $-15,560,000 | $-18,563,000 |
| Diluted Average Shares | $7,384,000 | $1,214,000 | $226,750 | $100,125 |
| Basic Average Shares | $7,384,000 | $1,214,000 | $226,750 | $100,125 |
| Diluted NI Availto Com Stockholders | $-12,556,000 | $-13,673,000 | $-15,581,000 | $-18,917,000 |
| Gain On Sale Of Security | $236,000 | $183,000 | $167,000 | $180,000 |
| Research And Development | $2,149,000 | $2,603,000 | $3,163,000 | $2,828,000 |
| Selling General And Administration | $13,001,000 | $12,874,000 | $13,805,000 | $15,256,000 |
| Other Gand A | $6,975,000 | $7,765,000 | $7,027,000 | $7,423,000 |
| Minority Interests | - | - | - | $0 |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $2,148,000 | $5,971,000 | $778,000 | $6,252,000 |
| Total Assets | $10,760,000 | $9,843,000 | $6,345,000 | $11,089,000 |
| Total Non Current Assets | $3,992,000 | $1,633,000 | $2,456,000 | $1,742,000 |
| Non Current Prepaid Assets | $51,000 | $51,000 | $51,000 | $51,000 |
| Non Current Deferred Assets | $0 | $431,000 | $798,000 | $25,000 |
| Goodwill And Other Intangible Assets | $2,892,000 | $0 | - | - |
| Other Intangible Assets | $485,000 | - | - | - |
| Current Assets | $6,768,000 | $8,210,000 | $3,889,000 | $9,347,000 |
| Other Current Assets | $260,000 | $206,000 | $389,000 | - |
| Inventory | $1,054,000 | $606,000 | $554,000 | $415,000 |
| Receivables | $1,698,000 | $863,000 | $518,000 | $228,000 |
| Accounts Receivable | $1,698,000 | $863,000 | $518,000 | $228,000 |
| Cash Cash Equivalents And Short Term Investments | $3,756,000 | $6,535,000 | $2,428,000 | $8,570,000 |
| Cash And Cash Equivalents | $3,756,000 | $6,535,000 | $2,428,000 | $2,129,000 |
| Prepaid Assets | - | - | $389,000 | $134,000 |
| Allowance For Doubtful Accounts Receivable | - | - | $0 | $0 |
| Gross Accounts Receivable | - | - | $518,000 | $228,000 |
| Debt | ||||
| Total Debt | $141,000 | $428,000 | $1,857,000 | $911,000 |
| Long Term Debt And Capital Lease Obligation | $0 | $141,000 | $428,000 | $683,000 |
| Current Debt And Capital Lease Obligation | $141,000 | $287,000 | $1,429,000 | $228,000 |
| Current Debt | - | - | $1,173,000 | - |
| Other Current Borrowings | - | - | $1,173,000 | - |
| Net Debt | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $5,720,000 | $3,872,000 | $5,567,000 | $4,837,000 |
| Total Non Current Liabilities Net Minority Interest | $2,507,000 | $2,003,000 | $2,427,000 | $2,307,000 |
| Other Non Current Liabilities | $993,000 | - | - | - |
| Current Liabilities | $3,213,000 | $1,869,000 | $3,140,000 | $2,530,000 |
| Payables And Accrued Expenses | $2,362,000 | $1,166,000 | $1,377,000 | $1,850,000 |
| Payables | $845,000 | $369,000 | $433,000 | $550,000 |
| Accounts Payable | $845,000 | $369,000 | $433,000 | $550,000 |
| Equity | ||||
| Common Stock Equity | $1,966,000 | $2,219,000 | $778,000 | $6,252,000 |
| Preferred Stock Equity | $3,074,000 | $3,752,000 | - | - |
| Total Equity Gross Minority Interest | $5,040,000 | $5,971,000 | $778,000 | $6,252,000 |
| Stockholders Equity | $5,040,000 | $5,971,000 | $778,000 | $6,252,000 |
| Retained Earnings | $-81,302,000 | $-68,746,000 | $-55,073,000 | $-39,492,000 |
| Gains Losses Not Affecting Retained Earnings | - | $0 | $-46,000 | $-100,000 |
| Other Equity Adjustments | - | - | $-46,000 | $-100,000 |
| Preferred Securities Outside Stock Equity | - | - | - | $0 |
| Other | ||||
| Ordinary Shares Number | $10,851,273 | $3,138,804 | $325,038 | $140,460 |
| Share Issued | $10,851,273 | $3,138,804 | $325,038 | $140,460 |
| Tangible Book Value | $-926,000 | $2,219,000 | $778,000 | $6,252,000 |
| Invested Capital | $1,966,000 | $2,219,000 | $1,951,000 | $6,252,000 |
| Working Capital | $3,555,000 | $6,341,000 | $749,000 | $6,817,000 |
| Capital Lease Obligations | $141,000 | $428,000 | $684,000 | $911,000 |
| Total Capitalization | $5,040,000 | $5,971,000 | $778,000 | $6,252,000 |
| Additional Paid In Capital | $83,257,000 | $70,962,000 | $55,897,000 | $45,843,000 |
| Capital Stock | $3,085,000 | $3,755,000 | $0 | $1,000 |
| Common Stock | $11,000 | $3,000 | $0 | $1,000 |
| Preferred Stock | $3,074,000 | $3,752,000 | $0 | - |
| Non Current Accrued Expenses | $1,514,000 | $1,862,000 | $1,999,000 | $1,624,000 |
| Long Term Capital Lease Obligation | $0 | $141,000 | $428,000 | $683,000 |
| Current Capital Lease Obligation | $141,000 | $287,000 | $256,000 | $228,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $710,000 | $416,000 | $334,000 | $452,000 |
| Current Accrued Expenses | $1,517,000 | $797,000 | $944,000 | $1,300,000 |
| Goodwill | $2,407,000 | $0 | - | - |
| Net PPE | $1,049,000 | $1,151,000 | $1,607,000 | $1,666,000 |
| Accumulated Depreciation | $-906,000 | $-668,000 | $-273,000 | $-80,000 |
| Gross PPE | $1,955,000 | $1,819,000 | $1,880,000 | $1,746,000 |
| Leases | $15,000 | $15,000 | $15,000 | $0 |
| Construction In Progress | $836,000 | $541,000 | $602,000 | $601,000 |
| Other Properties | $1,039,000 | $1,198,000 | $1,198,000 | $1,080,000 |
| Machinery Furniture Equipment | $65,000 | $65,000 | $65,000 | $65,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $1,033,000 | $585,000 | $532,000 | $406,000 |
| Raw Materials | $21,000 | $21,000 | $22,000 | $9,000 |
| Treasury Shares Number | - | - | $0 | - |
| Other Short Term Investments | - | - | $0 | $6,441,000 |
| Minority Interest | - | - | - | $0 |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-11,018,000 | $-10,064,000 | $-12,544,000 | $-12,872,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-10,745,000 | $-9,878,000 | $-12,183,000 | $-12,025,000 |
| Cash Flow From Continuing Operating Activities | $-10,745,000 | $-9,878,000 | $-12,183,000 | $-12,025,000 |
| Operating Gains Losses | - | - | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-273,000 | $-186,000 | $-361,000 | $-847,000 |
| Investing Cash Flow | $-1,023,000 | $-186,000 | $6,142,000 | $-2,884,000 |
| Cash Flow From Continuing Investing Activities | $-1,023,000 | $-186,000 | $6,142,000 | $-2,884,000 |
| Net Other Investing Changes | $-750,000 | - | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $6,860,000 | $9,761,000 | $5,303,000 | $14,139,000 |
| Financing Cash Flow | $8,989,000 | $14,125,000 | $6,302,000 | $14,114,000 |
| Cash Flow From Continuing Financing Activities | $8,989,000 | $14,125,000 | $6,302,000 | $14,114,000 |
| Net Other Financing Charges | $-928,000 | $-1,096,000 | $-509,000 | $-25,000 |
| Net Preferred Stock Issuance | $0 | $3,155,000 | $0 | - |
| Preferred Stock Issuance | $0 | $3,155,000 | $0 | - |
| Net Common Stock Issuance | $6,860,000 | $6,606,000 | $5,303,000 | $14,139,000 |
| Common Stock Issuance | $6,860,000 | $6,606,000 | $5,303,000 | $14,139,000 |
| Other | ||||
| End Cash Position | $3,756,000 | $6,535,000 | $2,428,000 | $2,129,000 |
| Beginning Cash Position | $6,535,000 | $2,428,000 | $2,129,000 | $2,917,000 |
| Effect Of Exchange Rate Changes | $0 | $46,000 | $38,000 | $7,000 |
| Changes In Cash | $-2,779,000 | $4,061,000 | $261,000 | $-795,000 |
| Proceeds From Stock Option Exercised | $3,057,000 | $5,460,000 | $258,000 | $0 |
| Net PPE Purchase And Sale | $-273,000 | $-186,000 | $-361,000 | $-847,000 |
| Purchase Of PPE | $-273,000 | $-186,000 | $-361,000 | $-847,000 |
| Change In Working Capital | $-426,000 | $-746,000 | $-1,173,000 | $1,722,000 |
| Change In Other Current Liabilities | $-287,000 | $-256,000 | $-227,000 | $-202,000 |
| Change In Payables And Accrued Expense | $1,134,000 | $-235,000 | $-216,000 | $2,360,000 |
| Change In Accrued Expense | $648,000 | $-171,000 | $-99,000 | $2,288,000 |
| Change In Payable | $486,000 | $-64,000 | $-117,000 | $72,000 |
| Change In Account Payable | $486,000 | $-64,000 | $-117,000 | $72,000 |
| Change In Prepaid Assets | $-35,000 | $183,000 | $-301,000 | $-57,000 |
| Change In Inventory | $-387,000 | $-52,000 | $-139,000 | $-227,000 |
| Change In Receivables | $-851,000 | $-386,000 | $-290,000 | $-152,000 |
| Changes In Account Receivables | $-851,000 | $-386,000 | $-290,000 | $-152,000 |
| Stock Based Compensation | $1,691,000 | $3,845,000 | $4,145,000 | $2,897,000 |
| Provisionand Write Offof Assets | $16,000 | $41,000 | $0 | - |
| Depreciation Amortization Depletion | $530,000 | $655,000 | $426,000 | $289,000 |
| Depreciation And Amortization | $530,000 | $655,000 | $426,000 | $289,000 |
| Depreciation | $530,000 | $655,000 | $426,000 | $289,000 |
| Net Income From Continuing Operations | $-12,556,000 | $-13,673,000 | $-15,581,000 | $-18,917,000 |
| Issuance Of Debt | - | $0 | $1,250,000 | $0 |
| Net Issuance Payments Of Debt | - | $0 | $1,250,000 | $0 |
| Net Short Term Debt Issuance | - | $0 | $1,250,000 | $0 |
| Short Term Debt Issuance | - | $0 | $1,250,000 | $0 |
| Net Investment Purchase And Sale | - | $0 | $6,503,000 | $-2,037,000 |
| Sale Of Investment | - | $0 | $6,996,000 | $8,079,000 |
| Purchase Of Investment | - | $0 | $-493,000 | $-10,116,000 |
| Interest Paid Supplemental Data | - | - | $0 | $0 |
| Income Tax Paid Supplemental Data | - | - | $0 | $0 |
| Unrealized Gain Loss On Investment Securities | - | - | $0 | $-16,000 |
| Asset Impairment Charge | - | - | $0 | $77,000 |
| Repayment Of Debt | - | - | - | $0 |
| Net Long Term Debt Issuance | - | - | - | $0 |
| Long Term Debt Payments | - | - | - | $0 |
| Long Term Debt Issuance | - | - | - | $0 |
| Other Non Cash Items | - | - | - | $1,923,000 |
| Gain Loss On Investment Securities | - | - | - | - |